PRODH and breast carcinoma: On the other hand, proline degradation by proline dehydrogenase (PRODH) sustains breast cancer metastases and promotes epithelial to mesenchymal transition in lung cancer, effects sensitive to PRODH inhibitor L-tetrahydro-2-furoic acid (L-THFA) (164, 165).